With its pipeline expanding beyond its initial focus on in vivo programming of myeloid cells, for which the company took its initial name, Myeloid Therapeutics has rebranded as Create Medicines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback